vs
CUMBERLAND PHARMACEUTICALS INC（CPIX）与Digimarc CORP（DMRC）财务数据对比。点击上方公司名可切换其他公司
CUMBERLAND PHARMACEUTICALS INC的季度营收约是Digimarc CORP的1.5倍（$13.7M vs $8.9M），CUMBERLAND PHARMACEUTICALS INC净利率更高（-10.3% vs -47.2%，领先36.9%），CUMBERLAND PHARMACEUTICALS INC同比增速更快（31.1% vs 2.9%），Digimarc CORP自由现金流更多（$895.0K vs $3.0K），过去两年CUMBERLAND PHARMACEUTICALS INC的营收复合增速更高（26.9% vs -5.3%）
坎伯兰制药是一家专科制药企业，专注于开发、生产和商业化品牌处方药物，核心产品覆盖急症护理、胃肠病、疼痛管理及罕见病治疗领域，主要运营市场为美国，为相关医护人员与患者提供服务。
迪吉马克公司是一家企业软件与服务提供商，其主打产品包含带数字标识符的软件，主要用于解决防伪问题、验证产品真伪、提升回收准确性以及实现供应链可追溯，产品可广泛应用于服装、快消品、美妆健康、汽车等多个行业领域。
CPIX vs DMRC — 直观对比
营收规模更大
CPIX
是对方的1.5倍
$8.9M
营收增速更快
CPIX
高出28.2%
2.9%
净利率更高
CPIX
高出36.9%
-47.2%
自由现金流更多
DMRC
多$892.0K
$3.0K
两年增速更快
CPIX
近两年复合增速
-5.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.7M | $8.9M |
| 净利润 | $-1.4M | $-4.2M |
| 毛利率 | 83.6% | 63.5% |
| 营业利润率 | -10.0% | -48.2% |
| 净利率 | -10.3% | -47.2% |
| 营收同比 | 31.1% | 2.9% |
| 净利润同比 | 25.8% | 51.4% |
| 每股收益（稀释后） | $-0.09 | $-0.18 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CPIXDMRC
| Q4 25 | $13.7M | $8.9M | ||
| Q3 25 | $8.3M | $7.6M | ||
| Q2 25 | $10.8M | $8.0M | ||
| Q1 25 | $11.7M | $9.4M | ||
| Q4 24 | $10.4M | $8.7M | ||
| Q3 24 | $9.1M | $9.4M | ||
| Q2 24 | $9.8M | $10.4M | ||
| Q1 24 | $8.5M | $9.9M |
净利润CPIXDMRC
| Q4 25 | $-1.4M | $-4.2M | ||
| Q3 25 | $-1.9M | $-8.2M | ||
| Q2 25 | $-740.7K | $-8.2M | ||
| Q1 25 | $1.3M | $-11.7M | ||
| Q4 24 | $-1.9M | $-8.6M | ||
| Q3 24 | $-1.5M | $-10.8M | ||
| Q2 24 | $-1.1M | $-9.3M | ||
| Q1 24 | $-1.9M | $-10.3M |
毛利率CPIXDMRC
| Q4 25 | 83.6% | 63.5% | ||
| Q3 25 | 88.1% | 58.3% | ||
| Q2 25 | 81.4% | 58.8% | ||
| Q1 25 | 87.8% | 65.0% | ||
| Q4 24 | 81.1% | 60.8% | ||
| Q3 24 | 85.4% | 62.4% | ||
| Q2 24 | 82.6% | 66.1% | ||
| Q1 24 | 81.5% | 62.5% |
营业利润率CPIXDMRC
| Q4 25 | -10.0% | -48.2% | ||
| Q3 25 | -23.7% | -109.7% | ||
| Q2 25 | -6.9% | -105.2% | ||
| Q1 25 | 11.0% | -128.9% | ||
| Q4 24 | -17.7% | -105.1% | ||
| Q3 24 | -18.6% | -120.4% | ||
| Q2 24 | -10.4% | -96.2% | ||
| Q1 24 | -22.0% | -109.2% |
净利率CPIXDMRC
| Q4 25 | -10.3% | -47.2% | ||
| Q3 25 | -23.4% | -106.9% | ||
| Q2 25 | -6.8% | -102.6% | ||
| Q1 25 | 10.7% | -125.2% | ||
| Q4 24 | -18.2% | -99.9% | ||
| Q3 24 | -17.0% | -113.9% | ||
| Q2 24 | -11.0% | -89.3% | ||
| Q1 24 | -22.9% | -104.0% |
每股收益（稀释后）CPIXDMRC
| Q4 25 | $-0.09 | $-0.18 | ||
| Q3 25 | $-0.13 | $-0.38 | ||
| Q2 25 | $-0.05 | $-0.38 | ||
| Q1 25 | $0.08 | $-0.55 | ||
| Q4 24 | $-0.13 | $-0.40 | ||
| Q3 24 | $-0.11 | $-0.50 | ||
| Q2 24 | $-0.08 | $-0.43 | ||
| Q1 24 | $-0.14 | $-0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.4M | $12.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $24.9M | $40.2M |
| 总资产 | $76.8M | $53.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CPIXDMRC
| Q4 25 | $11.4M | $12.9M | ||
| Q3 25 | $15.2M | $12.6M | ||
| Q2 25 | $16.1M | $16.1M | ||
| Q1 25 | $15.1M | $21.6M | ||
| Q4 24 | $18.0M | $28.7M | ||
| Q3 24 | $17.5M | $33.7M | ||
| Q2 24 | $17.3M | $41.5M | ||
| Q1 24 | $18.5M | $48.9M |
股东权益CPIXDMRC
| Q4 25 | $24.9M | $40.2M | ||
| Q3 25 | $26.1M | $41.4M | ||
| Q2 25 | $28.0M | $46.5M | ||
| Q1 25 | $28.7M | $50.0M | ||
| Q4 24 | $22.9M | $61.4M | ||
| Q3 24 | $24.8M | $70.2M | ||
| Q2 24 | $26.3M | $77.2M | ||
| Q1 24 | $27.5M | $84.5M |
总资产CPIXDMRC
| Q4 25 | $76.8M | $53.0M | ||
| Q3 25 | $65.9M | $55.4M | ||
| Q2 25 | $67.9M | $60.7M | ||
| Q1 25 | $69.9M | $66.5M | ||
| Q4 24 | $75.6M | $75.8M | ||
| Q3 24 | $76.7M | $85.0M | ||
| Q2 24 | $78.5M | $93.4M | ||
| Q1 24 | $81.5M | $99.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0K | $991.0K |
| 自由现金流经营现金流 - 资本支出 | $3.0K | $895.0K |
| 自由现金流率自由现金流/营收 | 0.0% | 10.0% |
| 资本支出强度资本支出/营收 | 0.0% | 1.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $4.8M | $-12.3M |
8季度趋势，按日历期对齐
经营现金流CPIXDMRC
| Q4 25 | $3.0K | $991.0K | ||
| Q3 25 | $187.2K | $-2.6M | ||
| Q2 25 | $843.8K | $-4.7M | ||
| Q1 25 | $3.9M | $-5.5M | ||
| Q4 24 | $1.9M | $-4.2M | ||
| Q3 24 | $475.5K | $-7.1M | ||
| Q2 24 | $-855.7K | $-6.8M | ||
| Q1 24 | $-2.1M | $-8.4M |
自由现金流CPIXDMRC
| Q4 25 | $3.0K | $895.0K | ||
| Q3 25 | $163.4K | $-2.8M | ||
| Q2 25 | $817.3K | $-4.9M | ||
| Q1 25 | $3.9M | $-5.5M | ||
| Q4 24 | $1.9M | $-4.2M | ||
| Q3 24 | $460.1K | $-7.2M | ||
| Q2 24 | $-862.8K | $-6.9M | ||
| Q1 24 | $-2.2M | $-8.5M |
自由现金流率CPIXDMRC
| Q4 25 | 0.0% | 10.0% | ||
| Q3 25 | 2.0% | -36.9% | ||
| Q2 25 | 7.5% | -61.0% | ||
| Q1 25 | 32.9% | -59.1% | ||
| Q4 24 | 18.2% | -49.1% | ||
| Q3 24 | 5.1% | -75.7% | ||
| Q2 24 | -8.8% | -66.1% | ||
| Q1 24 | -25.6% | -85.8% |
资本支出强度CPIXDMRC
| Q4 25 | 0.0% | 1.1% | ||
| Q3 25 | 0.3% | 2.9% | ||
| Q2 25 | 0.2% | 2.5% | ||
| Q1 25 | 0.4% | 0.6% | ||
| Q4 24 | 0.0% | 0.2% | ||
| Q3 24 | 0.2% | 0.7% | ||
| Q2 24 | 0.1% | 0.3% | ||
| Q1 24 | 0.5% | 1.1% |
现金转化率CPIXDMRC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.10× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CPIX
暂无分部数据
DMRC
| Subscription | $5.3M | 60% |
| The Government | $3.6M | 41% |
